[ 123 I]FP-CIT SPECT findings in two patients with Hallervorden–Spatz disease with homozygous mutation in PANK2 gene
- 11 January 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 64 (1), 167-168
- https://doi.org/10.1212/01.wnl.0000148577.62644.77
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden‐Spatz syndrome) and pantothenate kinase‐associated neurodegenerationMovement Disorders, 2004
- 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyNeurological Sciences, 2003
- Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene.Zeitschrift für Neurologie, 2002
- A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndromeNature Genetics, 2001
- Diagnosis of Hallervorden-Spatz Disease Using MRI, 123I-Beta-CIT-SPECT and 123I-IBZM-SPECTEuropean Neurology, 2000
- Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in lifeZeitschrift für Neurologie, 1992